This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hameln Pharma Plus Gmbh. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Mathias Dewald: Innovator in Pharmaceutical Chemistry
Introduction
Mathias Dewald is a notable inventor based in Hameln, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds. His work has implications for various medical applications, showcasing his expertise and innovative spirit.
Latest Patents
Mathias Dewald holds a patent for the production of crystalline forms of zinc trisodium pentetic acid (Zn-DTPA). This invention relates to the creation of new crystalline forms of this important salt, which is used in various medical treatments. His patent portfolio includes 1 patent, reflecting his focused contributions to the field.
Career Highlights
Dewald is associated with Hameln Pharma Plus GmbH, a company known for its commitment to pharmaceutical innovation. His role at the company allows him to work on cutting-edge projects that advance medical science. His expertise in chemistry and dedication to research have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Mathias has collaborated with talented professionals such as Vendel Smahovský and Ivan Kakalik. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions in pharmaceutical chemistry.
Conclusion
Mathias Dewald's contributions to the field of pharmaceutical chemistry, particularly through his patent on zinc trisodium pentetic acid, highlight his innovative capabilities. His work at Hameln Pharma Plus GmbH and collaborations with other professionals further emphasize his commitment to advancing medical science.